Skip to main content

Table 4 Sensitivity analysis (costs of scenarios 3 to 5 estimated on the 189 episodes of illness assuming that 50% of malaria-negative patients were treated with anti-malarials (October 2008 and January 2009).

From: Use of HRP-2-based rapid diagnostic test for Plasmodium falciparum malaria: assessing accuracy and cost-effectiveness in the villages of Dielmo and Ndiop, Senegal

 

RDT Positive

RDT Negative

EI treated

Cost of RDT & ACT

Total cost (study sample)

Total cost per 1000 EI*

Scenario 3 modified: Treatment of all EI* RDT positive & 50% of EI RDT negative

(number of RDT = 189, number of ACT course = 102)

RDT cost

   

115.29

  

ACT cost

   

95.89

211.18

1117.35

1-6 y

6

92

52

24.4

  

7-13 y

4

27

17.5

15.2

  

> 13 y

5

55

32.5

56.2

  

Scenario 4 modified: Treatment of febrile EI* RDT positive & 50% of febrile EI RDT negative

(number of RDT = 94, number of ACT course = 51)

RDT cost

   

57.95

  

ACT cost

   

36.05

94.00

497.35

1-6 y

6

64

38

17.86

  

7-13 y

1

8

5

4.35

  

> 13 y

1

14

8

13.84

  

Scenario 5 modified: Treatment of all children ≤ 6 and of all EI* RDT positive & 50% of EI RDT negative for patients > 6

(number of RDT = 91, number of ACT course = 88)

RDT cost

   

55.51

  

ACT cost

   

117.51

173.02

915.45

1-6 y

  

98

46.06

  

7-13 y

4

27

17.5

15.22

  

> 13 y

5

55

32.5

56.23